Quoin Pharmaceuticals annual operating expenses
2017
2019
2020
2021
2022
2023
2024
2025
Quoin Pharmaceuticals Operating Expenses Growth & History (QNRX)
Quoin Pharmaceuticals's operating expenses was $16.3M for fiscal 2025.
View full Quoin Pharmaceuticals company overviewQuoin Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.3M | $6.8M | +70.97% |
| 2024 | 2024-12-31 | $9.5M | $149,961 | +1.60% |
| 2023 | 2023-12-31 | $9.4M | $120,800 | +1.30% |
| 2022 | 2022-12-31 | $9.3M | $3.2M | +52.70% |
| 2021 | 2021-12-31 | $6.1M | $4.4M | +263.04% |
| 2020 | 2020-12-31 | $1.7M | $109,609 | +7.02% |
| 2019 | 2019-12-31 | $1.6M | — | — |
| 2017 | 2017-12-31 | $7.0M | — | — |
Quoin Pharmaceuticals quarterly operating expenses
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.5M | $1.7M | +44.30% |
| Q1 2026 | 2026-03-31 | $5.1M | $1.2M | +29.67% |
| Q4 2025 | 2025-12-31 | $4.5M | $2.1M | +87.96% |
| Q3 2025 | 2025-09-30 | $4.0M | $1.5M | +59.02% |
| Q2 2025 | 2025-06-30 | $3.8M | $1.7M | +77.49% |
| Q1 2025 | 2025-03-31 | $4.0M | $1.5M | +60.97% |
| Q4 2024 | 2024-12-31 | $2.4M | $187,394 | +8.45% |
| Q3 2024 | 2024-09-30 | $2.5M | $402,779 | +18.95% |
| Q2 2024 | 2024-06-30 | $2.1M | −$122,946 | −5.44% |
| Q1 2024 | 2024-03-31 | $2.5M | −$317,266 | −11.43% |
| Q4 2023 | 2023-12-31 | $2.2M | $131,734 | +6.32% |
| Q3 2023 | 2023-09-30 | $2.1M | −$202,342 | −8.69% |
| Q2 2023 | 2023-06-30 | $2.3M | −$408,103 | −15.30% |
| Q1 2023 | 2023-03-31 | $2.8M | $599,511 | +27.55% |
| Q4 2022 | 2022-12-31 | $2.1M | — | — |
| Q3 2022 | 2022-09-30 | $2.3M | $1.0M | +78.66% |
| Q2 2022 | 2022-06-30 | $2.7M | $1.7M | +173.13% |
| Q1 2022 | 2022-03-31 | $2.2M | — | — |
| Q3 2021 | 2021-09-30 | $1.3M | — | — |
| Q2 2021 | 2021-06-30 | $976,890 | — | — |
Quoin Pharmaceuticals operating expenses trends
Over the last five fiscal years, Quoin Pharmaceuticals's operating expenses increased from $1.7M to $16.3M, a change of $14.6M. The latest reported quarter, Q2 2026, shows $5.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quoin Pharmaceuticals source filings ↗